Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00219648
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
INDUSTRY
Sponsor class
Conditions
COPD
Interventions
DRUG:
PEP03
Sponsor
PharmaEngine